Next, we hypothesized that the anti-TCP1 antibody could be a better biomarker than the anti-RPLP0, RPLP1, and RPLP2 antibodies, which were already known lupus autoantibodies. This evidence concerns the gene RPLP0 and systemic lupus erythematosus.